价格

AMD therapy

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT
EP 3795181 B1申请人: ADVERUM BIOTECHNOLOGIES INC优先权: 2016
CN
EP
US
WO
8 件公开
PEGYLATED COMPOUNDS FOR AGE-RELATED MACULAR DEGENERATION
US 2010247626 A1申请人: ALBRECHT VOLKER优先权: 2007
EP
US
WO
4 件公开
FUNCTIONAL BIOMARKERS FOR STATIN THERAPY IN AGE-RELATED MACULAR DEGENERATION (AMD)
EP 3697285 A4申请人: APELIOTUS TECH INC优先权: 2017
EP
US
WO
4 件公开
RETINAL DISORDERS
- EP 4355886 A1
  申请人: IKAROVEC LTD优先权: 2021
  EP
  US
  WO
  4 件公开
- EP 4355767 A1
  申请人: IKAROVEC LTD优先权: 2021
  EP
  US
  WO
  3 件公开
CHOROIDAL NEOVASCULARIZATION SUPPRESSOR OR DRUSEN FORMATION SUPPRESSOR, AND METHOD FOR ASSESSING OR SCREENING FOR SAME
EP 3391883 B1申请人: LINK GENOMICS INC优先权: 2015
EP
US
4 件公开
Materials and methods for the treatment of pathological neovascularization in the eye
US 8785413 B2申请人: BLANKS JANET C优先权: 2011
US
4 件公开
NUCLEIC ACID ENCODING AN ANTI-VEGF ENTITY AND A NEGATIVE COMPLEMENT REGULATOR AND USES THEREOF FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
EP 4229076 A1申请人: GYROSCOPE THERAPEUTICS LTD优先权: 2020
EP
US
WO
3 件公开
MULTIGENE CONSTRUCTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER COMPLEMENT DYSREGULATION-RELATED CONDITIONS
EP 4387678 A4申请人: UNIV UTAH RES FOUND优先权: 2021
EP
US
WO
3 件公开
METHOD OF TREATING AMD IN PATIENTS REFRACTORY TO ANTI-VEGF THERAPY
EP 3646880 A1申请人: ALLERGAN INC优先权: 2012
EP
US
3 件公开
AAV-EXPRESSED M013 PROTEIN AS AN ANTI-INFLAMMATROY THERAPEUTIC FOR USE IN A METHOD OF TREATING INFLAMMATORY OCULAR DISEASE
EP 4050020 A1申请人: UNIV FLORIDA优先权: 2014
EP
US
2 件公开

药物

AMD therapy

专利

RETINAL DISORDERS